Prognosis of intestinal metaplasia and expressions of biomarkers in high-risk populations of gastric cancer in Shangdong province

Yang Zhang,Lian Zhang,Kai-Feng Pan,Wei-Cheng You,Ji-You Li
DOI: https://doi.org/10.11569/wcjd.v14.i23.2306
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the relationship between the expression of biomarkers and the prognosis of hyperproliferative intestinal metaplasia (HIM) and usual intestinal metaplasia (UIM) in Padova and Vienna international classification. METHODS: The risk of progression to dysplasia or gastric cancer in patients with UIM or HIM was estimated in a prospective study in Chinese populations at high risk area of gastric cancer from 1992 to 2001 in Shandong province. The cases included 2 groups: progressive group (n = 27) and non-progressive group (n = 60). Immu-nohistochemistry was used to detect the expres- sions of pS2, MUC5AC, MUC6 and Ki-67 in both groups. RESULTS: HIM had a higher risk of dysplasia or gastric cancer than UIM (OR = 7.23, 95%CI 2.59-20.20). The risk of dysplasia or gastric cancer was reduced in IM with the expression of MUC5 (OR = 0.27, 95%CI 0.10-0.73) or pS2 (OR = 0.33, 95%CI 0.12-0.90). Ki-67 labeling index was elevated in progressive IM in comparison with that in non-progressive one (28.5%±14.3% vs 16.4%±9.8%, P < 0.01). An elevated risk of dysplasia or gastric cancer was observed in patients with HIM and negative expression of MUC5AC (OR = 10.40, 95%CI 2.99-36.21). The expression of was also higher in progressive IM than that in non-progressive one (OR = 1.56,95%CI 0.53-4.60), but the difference was not significant. CONCLUSION: HIM has a higher risk of progression to dysplasia or gastric cancer than UIM. It may be helpful to evaluate the prognosis of IM by combining the histological classification and the detection of some biomarkers, such as Ki-67, MUC5AC and pS2.
What problem does this paper attempt to address?